Intravascular Neuro OCT Imaging System for Aneurysm Treatment Evaluation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorSpryte Medical

About this trial

This is an investigational study for a new medical device called the nOCT (neuro optical coherence tomography) Imaging System, which is manufactured by Spryte Medical, LLC. The nOCT Imaging System takes pictures from inside a blood vessel in your brain. These pictures give your doctor information about the inside of your blood vessel including the disease and any implanted devices.

The nOCT Imaging System consists of a probe and a console. The probe is a small, flexible wire-like device designed to navigate through catheters which have already been inserted in your body as part of your planned procedure. Catheters are small, flexible, tubes inserted in your blood vessels which allow your doctor to deliver treatments such as medications, coils, or stents directly to the affected area. The console is a unit that includes a computer, screen and laser light source. The probe is connected to the console. The console provides the probe with low-power light from the laser which is used to scan and create pictures of your blood vessel. The pictures are displayed on the screen of the console for review by your doctor and may be stored for future viewing.

The objective of the study is to evaluate the safety and effectiveness of the nOCT Imaging System to provide quality images for diagnostic assessment during endovascular intracranial aneurysm treatment and follow-up.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Single group

Treatments tested in this trial

  • Endovascular Intracranial aneurysm treatment

    Procedure/Surgery

    Endovascular Intracranial aneurysm treatment using devices such as coils, flow diverters, etc. The treatment will include devices that are all FDA approved.

  • nOCT imaging

    Device

    During the aneurysm treatment and during the subsequent follow-up, nOCT imaging will be performed.

Treatment groups

67 Participants
are divided into 1 treatment group
Group A: Single arm: Use of nOCT during treatment and follow-upExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Safety - Adverse Events

All peri-procedural adverse events (AE) from the index procedure.

Time frame
peri-procedural
2

Effectiveness

Image quality, defined as clear image length (CIL) for images obtained during the index procedure.

Time frame
peri-procedural

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.